The present invention relates to compounds useful as promoters of the SMN2 gene. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of Spinal Muscular Atrophy.

 
Web www.patentalert.com

< Hyaluronic acid modification product

> Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
~ 00484